Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (12 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net sales
125
189
253
251
181
206
181
Cost of products sold
118
156
205
210
167
174
171
Gross margin
0
0
47
41
14
32
10
Selling, general and administrative expenses
12
13
18
18
18
21
19
Severance expense
0
0
0
0
0
0
0
Goodwill impairment
0
0
0
0
0
0
20
Operating (loss) income
-5
20
30
23
-4
11
-30
Interest expense and other financing costs
0
0
-1
-3
-3
-4
-3
Other income (expense)
1
0
0
0
0
0
0
(Loss) income before income taxes
-4
20
28
21
-7
7
-33
(Benefit) provision for income taxes
-1
7
10
6
-3
3
-12
Net (loss) income
-3
13
18
15
-4
4
-21
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 5, 2014 n/a
calculated values,
restated on Feb 24, 2015 n/a
calculated values,
restated on Feb 24, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (31 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash
n/a
34
0
0
0
0
0
Accounts receivable (less allowance for doubtful accounts of $249 and $17, respectively)
n/a
29
35
25
21
29
18
Inventory, Net
n/a
70
85
96
83
101
83
Deferred income taxes
n/a
4
28
23
13
0
0
Refundable income taxes
n/a
0
5
0
0
0
0
Other current assets
n/a
1
2
3
4
3
3
Total current assets
n/a
139
155
147
121
133
104
Property, plant and equipment, net
n/a
72
183
206
204
200
194
Goodwill
n/a
0
20
20
20
20
0
Other long-term assets
n/a
0
3
2
3
2
0
Total assets
n/a
211
362
376
348
355
297
Liabilities and owners' equity
Accounts payable
n/a
20 20022000
30 29912000
11 10610000
14 14288000
25 25009000
12 11850000
Accrued employment costs
n/a
5 5488000
8 7547000
5 4671000
3 3430000
6 6011000
3 3256000
Current portion of long-term debt
n/a
3 2833000
3 3000000
2 1500000
3 3000000
3 3000000
3 3000000
Other current liabilities
n/a
0 481000
1 966000
1 735000
1 1023000
1 861000
1 640000
Total current liabilities
n/a
29 28824000
41 41425000
18 17516000
22 21741000
35 34881000
19 18746000
Long-term debt
n/a
8 7990000
92 91650000
105 105242000
87 86796000
84 83875000
73 72884000
Deferred income taxes
n/a
14 13877000
48 48291000
55 55227000
43 42532000
32 32425000
21 20666000
Other long-term liabilities
n/a
0 287000
0 0
0 0
0 397000
0 63000
0 29000
Total liabilities
n/a
51 50978000
181 181366000
178 177985000
151 151466000
151 151244000
112 112325000
Commitments and contingencies (Note 10)
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Senior preferred stock, par value $0.001 per share; 1,980,000 shares authorized; 0 shares issued and outstanding
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Common stock, par value $0.001 per share; 20,000,000 shares authorized, respectively; 7,404,193 and 7,371,018 shares issued, respectively
n/a
0 7000
0 7000
0 7000
0 7000
0 7000
0 7000
Additional paid-in capital
n/a
41 41341000
44 43720000
47 46744000
50 49688000
53 52810000
55 54829000
Retained earnings
n/a
120 120376000
138 138498000
153 153115000
149 149053000
153 153103000
132 132431000
Treasury stock, at cost; 292,855 common shares held, respectively
n/a
-2 -1919000
-2 -1919000
-2 -2153000
-2 -2290000
-2 -2290000
-2 -2290000
Accumulated other comprehensive loss
n/a
0 -182000
0 0
0 0
0 0
0 0
0 0
Total stockholders' equity
n/a
160 159623000
180 180306000
198 197713000
196 196458000
204 203630000
185 184977000
Total liabilities and stockholders' equity
n/a
211 210601000
362 361672000
376 375698000
348 347924000
355 354874000
297 297302000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Mar 5, 2014 n/a restated on Nov 30, -1 n/a restated on Feb 24, 2016 n/a restated on Jul 29, 2016 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (32 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net (loss) income
-3
13
18
15
-4
4
-21
Depreciation and amortization
5
5
9
14
16
17
19
Gain on sale of property, plant and equipment
0
0
0
0
0
0
0
Deferred Income Tax
2
1
10
13
-3
3
-12
Share-based compensation expense, net
1
2
2
2
2
2
2
Goodwill impairment
0
0
0
0
0
0
20
Accounts receivable, net
16
-12
-5
10
3
-8
11
Inventory, Net
22
-28
-17
-12
12
-20
16
Accounts payable
-13
12
0
-19
4
11
-13
Accrued employment costs
-3
4
2
-3
-1
3
-3
Income taxes
-2
4
-5
3
0
1
0
Other, net
1
0
-3
0
0
0
0
Net cash provided by operating activities
27
1
11
22
29
13
19
Capital expenditures
-11
-7
-17
-35
-12
-11
-10
Business acquisition, net of convertible notes assumed
0
0
-91
0
0
0
0
Proceeds from sale of property, plant and equipment
0
0
0
0
0
0
0
Proceeds from insurance recovery
0
0
0
0
0
0
0
Net cash used in investing activity
-11
-7
-108
-35
-12
-11
-9
Borrowings under revolving credit facility
0
0
66
119
77
104
74
Payments on revolving credit facility
0
0
-31
-87
-92
-104
-80
Payments on term loan facility
0
-2
0
-20
-2
-3
-3
Borrowings under term loan facility
12
0
40
0
0
0
0
Debt repayments
0
0
-11
0
0
0
0
Proceeds from the issuance of common stock
0
1
1
2
1
1
0
Payment of deferred financing costs
0
0
-1
0
-1
0
-1
Tax benefit from share-based payment arrangements
0
0
0
0
0
0
0
Purchase of treasury stock
0
0
0
0
0
0
0
State grant funding the purchase of new equipment
0
1
0
0
0
0
0
Net cash used in financing activities
12
-1
63
13
-17
-2
-10
Net Decrease in Cash
27
-7
-34
0
0
0
0
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 5, 2014 n/a
calculated values,
restated on Feb 24, 2015 n/a
calculated values,
restated on Feb 24, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo